This study is a retrospective analysis of all patients with EGFR exon19 mutation in Henan Cancer Hospital from 2015 to 2017, which aims to guide patients with advanced lung cancer to obtain more efficient treatment. This evidence concerns the gene EGFR and lung cancer.